Home / Dobutamine / Austria
AT ATC C01CA07 · updated 2 Nov 2026
Dobutamine shortage in Austria
Is there a Dobutamine shortage in Austria?
Yes. As of 2 Nov 2026, 2 Dobutamine products are reported short in Austria, the first since 30 Nov 2020. The company estimate for the return is 31 Dec 2027. Main reason: manufacturing problem.
Also short in United States, France, Italy, Japan. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Dobutamin "Pharmaselect" 250 mg - Infusionslösung, 5 Stück | Pharmaselect International Beteiligungs GmbH | 30 Nov 2020 | 31 Dec 2027 | Manufacturing problem Verzögerung in der Packmittelbeschaffung |
| AT | Dobutamin "Pharmaselect" 500 mg - Infusionslösung, 5 Stück | Pharmaselect International Beteiligungs GmbH | 30 Nov 2020 | not given | Manufacturing problem Verzögerung in der Packmittelbeschaffung |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).